 |
| |
| Apr-07-20 | Initiated |
Oppenheimer |
Outperform |
$25 |
|
| May-28-19 | Initiated |
Morgan Stanley |
Equal-Weight |
|
|
| May-28-19 | Initiated |
JP Morgan |
Overweight |
|
|
| May-28-19 | Initiated |
Cowen |
Outperform |
|
|
| May-28-19 | Initiated |
Canaccord Genuity |
Buy |
|
|
|
|
| Jun-04-20 10:11PM | |
| May-27-20 11:14AM | |
| May-26-20 06:50PM | |
| 07:14AM | |
| 07:09AM | |
| May-07-20 11:30AM | |
| May-06-20 04:05PM | |
| Apr-29-20 12:34PM | |
| Apr-23-20 04:05PM | |
| Apr-13-20 04:05PM | |
| Mar-17-20 09:20AM | |
| 07:00AM | |
| Mar-02-20 04:05PM | |
| Feb-20-20 04:05PM | |
| Feb-19-20 04:05PM | |
| Jan-17-20 09:39AM | |
| Dec-22-19 05:10PM | |
| Dec-19-19 08:00AM | |
| Dec-09-19 08:58AM | |
| Dec-04-19 08:00AM | |
| Nov-06-19 07:30AM | |
| Nov-01-19 02:17PM | |
| Oct-23-19 04:05PM | |
| Oct-16-19 04:05PM | |
| Sep-17-19 01:45PM | |
| Aug-26-19 04:05PM | |
| Aug-21-19 05:35PM | |
| Aug-07-19 04:05PM | |
| Aug-02-19 08:21AM | |
| Jul-30-19 08:30AM | |
| Jul-25-19 04:05PM | |
| Jul-17-19 04:05PM | |
| Jun-30-19 08:11AM | |
| Jun-11-19 04:05PM | |
| 02:30PM | |
| Jun-03-19 08:00AM | |
| May-30-19 04:05PM | |
| May-06-19 04:15PM | |
| May-01-19 01:25PM | |
|
|
|
|
| TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion apparatus, optimization, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Carey John F | VP of Operations | Jul 01 | Option Exercise | 1.40 | 2,000 | 2,793 | 5,200 | Jul 02 07:42 PM | | Carey John F | VP of Operations | Jul 01 | Sale | 17.09 | 2,000 | 34,174 | 3,200 | Jul 02 07:42 PM | | Carey John F | VP of Operations | Jun 01 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | Jun 02 06:10 PM | | Carey John F | VP of Operations | Jun 01 | Sale | 13.21 | 2,000 | 26,420 | 3,200 | Jun 02 06:10 PM | | Carey John F | VP of Operations | May 01 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | May 04 06:04 PM | | Carey John F | VP of Operations | May 01 | Sale | 17.05 | 2,000 | 34,105 | 3,200 | May 04 06:04 PM | | Gordon Stephen | Chief Financial Officer | Apr 27 | Sale | 18.00 | 9,900 | 178,200 | 18,571 | Apr 29 04:22 PM | | Gordon Stephen | Chief Financial Officer | Apr 22 | Sale | 18.00 | 100 | 1,800 | 28,471 | Apr 24 05:54 PM | | Carey John F | VP of Operations | Apr 07 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | Apr 09 04:33 PM | | Carey John F | VP of Operations | Apr 07 | Sale | 13.10 | 2,000 | 26,200 | 3,200 | Apr 09 04:33 PM | | Hassanein Waleed H | President & CEO | Mar 27 | Option Exercise | 0.39 | 100,000 | 39,000 | 215,429 | Mar 30 04:57 PM | | Carey John F | VP of Operations | Mar 02 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | Mar 04 04:30 PM | | Carey John F | VP of Operations | Mar 02 | Sale | 15.17 | 2,000 | 30,345 | 3,200 | Mar 04 04:30 PM | | Carey John F | VP of Operations | Feb 03 | Option Exercise | 0.39 | 2,000 | 780 | 3,200 | Feb 05 04:43 PM | | Carey John F | VP of Operations | Feb 03 | Sale | 17.71 | 2,000 | 35,420 | 1,200 | Feb 05 04:43 PM | | Khayal Tamer I | Chief Commercial Officer | Jan 21 | Option Exercise | 0.39 | 5,000 | 1,950 | 51,076 | Jan 22 04:20 PM | | Khayal Tamer I | Chief Commercial Officer | Jan 21 | Sale | 20.02 | 5,000 | 100,100 | 46,076 | Jan 22 04:20 PM | | Carey John F | VP of Operations | Jan 17 | Option Exercise | 0.28 | 2,000 | 560 | 3,200 | Jan 22 04:19 PM | | Carey John F | VP of Operations | Jan 02 | Option Exercise | 0.39 | 2,000 | 780 | 3,200 | Jan 06 04:55 PM | | Carey John F | VP of Operations | Jan 02 | Sale | 18.95 | 2,000 | 37,900 | 1,200 | Jan 06 04:55 PM | | UNITED THERAPEUTICS Corp | 10% Owner | Dec 09 | Sale | 18.75 | 500,000 | 9,375,000 | 2,053,240 | Dec 10 04:31 PM | | Carey John F | VP of Operations | Nov 15 | Option Exercise | 0.28 | 1,200 | 336 | 1,200 | Nov 18 04:39 PM | | Sullivan John F | VP of Quality & Engineering | Nov 15 | Option Exercise | 0.28 | 1,400 | 392 | 10,828 | Nov 18 04:38 PM | | Weill David | Director | Nov 11 | Buy | 17.00 | 10,000 | 170,000 | 10,000 | Nov 13 05:05 PM |
|
|
|
|
|
|
